462 related articles for article (PubMed ID: 18598106)
21. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
Angeloni D
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
[TBL] [Abstract][Full Text] [Related]
22. Genomics and proteomics in process development: opportunities and challenges.
Gupta P; Lee KH
Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
[TBL] [Abstract][Full Text] [Related]
23. Molecular profiling of laryngeal cancer.
Mäkitie AA; Monni O
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1251-60. PubMed ID: 19761429
[TBL] [Abstract][Full Text] [Related]
24. Exploring the human genome in cancer with genomic approaches.
Scheel JR; Kuo MD
J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
[No Abstract] [Full Text] [Related]
25. Integration of genomics, proteomics, and imaging for cardiac stem cell therapy.
Chun HJ; Wilson KO; Huang M; Wu JC
Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S20-6. PubMed ID: 17464506
[TBL] [Abstract][Full Text] [Related]
26. 'Normal' genes key to cancer growth.
Check Hayden E
Nature; 2008 Feb; 451(7179):615. PubMed ID: 18256629
[No Abstract] [Full Text] [Related]
27. Genomics and proteomics in predicting cancer outcomes.
Parikh AA; Johnson JC; Merchant NB
Surg Oncol Clin N Am; 2008 Apr; 17(2):257-77, vii. PubMed ID: 18375352
[TBL] [Abstract][Full Text] [Related]
28. Integrating cancer genomics and proteomics in the post-genome era.
Hanash SM; Bobek MP; Rickman DS; Williams T; Rouillard JM; Kuick R; Puravs E
Proteomics; 2002 Jan; 2(1):69-75. PubMed ID: 11788993
[TBL] [Abstract][Full Text] [Related]
29. Proteomics: clinical applications for head and neck squamous cell carcinoma.
Yarbrough WG; Slebos RJ; Liebler D
Head Neck; 2006 Jun; 28(6):549-58. PubMed ID: 16475197
[TBL] [Abstract][Full Text] [Related]
30. Cancer biomarkers--an invitation to the table.
Dalton WS; Friend SH
Science; 2006 May; 312(5777):1165-8. PubMed ID: 16728629
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathways in tumor progression: from discovery to functional understanding.
Ali MA; Sjöblom T
Mol Biosyst; 2009 Sep; 5(9):902-8. PubMed ID: 19668850
[TBL] [Abstract][Full Text] [Related]
32. The quest for the mechanisms of life.
Klapa MI; Quackenbush J
Biotechnol Bioeng; 2003 Dec; 84(7):739-42. PubMed ID: 14708113
[TBL] [Abstract][Full Text] [Related]
33. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
Ross JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
[No Abstract] [Full Text] [Related]
34. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
35. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Kulasingam V; Diamandis EP
Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
[TBL] [Abstract][Full Text] [Related]
36. Cancer genomics: integrating form and function.
Kim SY; Hahn WC
Carcinogenesis; 2007 Jul; 28(7):1387-92. PubMed ID: 17434922
[TBL] [Abstract][Full Text] [Related]
37. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
[TBL] [Abstract][Full Text] [Related]
38. Genes versus cancer.
Lewis R
Nature; 2007 Apr; 446(7137):826-7. PubMed ID: 17460827
[No Abstract] [Full Text] [Related]
39. Genomic profiling of breast cancer.
Pandey A; Singh AK; Maurya SK; Rai R; Tewari M; Kumar M; Shukla HS
J Surg Oncol; 2009 May; 99(6):386-92. PubMed ID: 19235775
[TBL] [Abstract][Full Text] [Related]
40. Database resources for proteomics-based analysis of cancer.
Zhang GL; DeLuca DS; Brusic V
Methods Mol Biol; 2011; 723():349-64. PubMed ID: 21370076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
